Understanding MPB: the biology of pattern progression.

1. How does DHT cause male pattern baldness?

DHT (dihydrotestosterone) causes male pattern baldness by binding to androgen receptors in genetically sensitive follicles, triggering a process called miniaturization that progressively shrinks each hair until it stops producing visible growth. Male Pattern Baldness, clinically known as Androgenetic Alopecia, is primarily driven by the interaction between circulating androgens and your scalp's genetic architecture. Understanding the mechanism is the first step to making evidence-based decisions about treatment and tracking.

• The Enzyme: 5-alpha reductase (5AR) is the catalyst that converts testosterone into Dihydrotestosterone (DHT). There are two types: Type I (found in sebaceous glands) and Type II (found in hair follicles and prostate). Type II is the primary driver of follicle miniaturization in MPB.
• The Sensitivity: It is not the amount of DHT that matters, but your follicles' sensitivity to it. This sensitivity is determined by the AR (androgen receptor) gene on the X chromosome, which is why maternal family history is a stronger predictor than paternal.
• The Result: When DHT binds to receptors in a sensitive follicle, it shortens the anagen (growth) phase and triggers miniaturization. Each successive hair cycle produces a thinner, shorter, less pigmented hair until the follicle effectively stops producing visible hair.

The Genetic Component

MPB is polygenic, meaning multiple genes contribute to the outcome. While the AR gene on the X chromosome is the most studied, research has identified over 200 genetic loci associated with hair loss susceptibility. This is why two brothers can have dramatically different hair loss patterns despite identical parents. Genetic testing can provide directional insight, but it cannot predict the exact pattern or timeline of hair loss for any individual.

2. What is hair miniaturization and how does it progress?

Hair miniaturization is the gradual shrinking of follicles over multiple hair cycles, producing progressively thinner, shorter, and less pigmented hairs until they become invisible peach fuzz. A common myth is that hair “falls out” and disappears. In reality, MPB is a slow shrinking process that happens over multiple hair cycles, typically spanning years or decades.

In every subsequent hair cycle, the follicle produces a hair that is slightly thinner, shorter, and less pigmented than the one before. Eventually, the “terminal” hair becomes a “vellus-like” hair - peach fuzz that is invisible to the naked eye. This is why consistent photo resolution is critical; you need to see the caliber of individual hairs, not just the overall shape.

The Stages of Miniaturization

A single follicle goes through these stages over the course of MPB:

1. Full Terminal: Thick, pigmented, long growth phase (2-7 years anagen).
2. Early Miniaturization: Slightly thinner caliber, shorter growth phase (1-3 years anagen). Barely noticeable to the naked eye, but visible under magnification.
3. Intermediate: Visibly thinner, shorter, possibly lighter in color. Growth phase shortened to months. This is where “thinning” becomes apparent in photos.
4. Late Miniaturization: Vellus-like hair. Fine, short, unpigmented. Functionally invisible. The follicle is still alive but producing peach fuzz.
5. Follicle Dormancy: Eventually, the follicle may stop cycling entirely. At this stage, no treatment can revive it. This is why early intervention matters.

3. Which scalp zones does male pattern baldness affect first?

Male pattern baldness typically affects the temples (frontal hairline) first, followed by the vertex (crown), and finally the mid-scalp bridge that connects them. MPB does not move randomly. It follows a geometric map described by the Norwood-Hamilton scale. Isolate these zones to eliminate visual noise and track each independently.

The Frontal Recession (Temples)

Usually the first area to show signal. Many men have a “mature hairline” which stabilizes in the early 20s, receding roughly 1-1.5 cm from the juvenile hairline. This is normal and not MPB. However, MPB continues to erode the temple peaks beyond the mature hairline position.The Protocol: Use the 45-degree angle scan. Look for the “V” depth becoming more acute over 6-month windows. Compare the temporal peaks relative to the mid-frontal hairline. If the V deepens while the mid-frontal stays stable, active recession is likely.

The Vertex (Crown) Thinning

The “silent” zone. Because you cannot easily see your own crown, anxiety often takes over.The Protocol: Use top-down scans with consistent lighting. If you see a widening of the natural hair whorl or increasing visibility of scalp through the hair, miniaturization is active. The crown typically thins in a circular pattern radiating outward from the central whorl.

Crown thinning often progresses independently from frontal recession. Some men have significant crown thinning with a stable hairline, and vice versa. Tracking both zones separately gives you a complete picture.

The Mid-Scalp Bridge

The last area to thin in most Norwood patterns. When this zone starts to diffuse, the overall “silhouette” of your hair changes and the frontal and vertex zones begin to merge. This typically represents a more advanced stage (Norwood 5-6). Track the part line width in this zone as an early indicator.

Diffuse Thinning (DUPA)

Some men experience diffuse unpatterned alopecia (DUPA), where miniaturization occurs relatively uniformly across the entire scalp rather than following the classic frontal-to-vertex pattern. DUPA is harder to detect with mirror checks because there is no obvious “bald spot.” It is best detected by comparing part line width and overall scalp visibility over time. If you suspect DUPA, tracking every zone is essential.

Free · takes 30 seconds

Identify your zone pattern now

Our AI identifies which specific zones are showing signs of miniaturization vs. normal density. Run your first full-head scan today.

How tracking works →

Your scans stay private. Delete or export anytime.

4. How can you tell if hair shedding is temporary or permanent?

You can tell the difference by examining the shed hairs themselves: temporary shedding (telogen effluvium) produces full-thickness hairs with white bulbs, while permanent pattern loss (MPB) produces thin, short, miniaturized hairs. Understanding Telogen Effluvium (TE) vs. MPB prevents 90% of bad decisions. TE is a temporary, reactive shedding event triggered by stress, illness, surgery, diet changes, or medication. MPB is a chronic, genetically driven process. The treatment approach, timeline, and prognosis are entirely different.

It is also possible to have both TE and MPB simultaneously. A stressful event can trigger TE on top of ongoing MPB, making the loss appear more dramatic. Tracking consistently over time helps separate the temporary TE component from the chronic MPB signal.

5. What do the Norwood scale stages mean for your hair loss?

The Norwood scale stages classify the pattern and extent of male hair loss from stage 1 (no recession) to stage 7 (extensive loss), but your rate of progression matters far more than your current stage number. The Norwood-Hamilton scale is the most widely used classification system for male pattern hair loss. It ranges from Norwood 1 (no recession, juvenile hairline) to Norwood 7 (extensive loss with only a horseshoe ring remaining). Understanding where you fall on this scale provides context, but it should not be treated as a verdict.

• Norwood 1-2: Minimal to no recession. Standard mature hairline. Most men reach Norwood 2 by their late 20s regardless of MPB.
• Norwood 2-3: Noticeable temple recession. The hairline takes on an M-shape. This is the ideal intervention window for most treatments.
• Norwood 3-4: Significant frontal loss, possibly early vertex thinning. Treatments can still maintain and sometimes improve, but expectations should be calibrated.
• Norwood 5-7: Advanced loss with frontal and vertex zones merging. Treatment focus shifts to maintenance of remaining hair and potential surgical options.

The key insight is that Norwood stages are descriptive, not prescriptive. Your rate of progression is far more important than your current stage. A Norwood 3 that has been stable for 5 years is very different from a Norwood 3 that reached that stage in 18 months.

6. What should you bring to a dermatologist for hair loss?

You should bring baseline photos, trend data across multiple 8-week windows, an adherence log of any treatments, and context notes about recent stressors or health changes. If you decide to see a dermatologist, don't arrive with “I think it looks thinner.” Arrive with Evidence-Based History.

• Baseline Photos: A full zone photo set from at least 12 weeks ago, captured with consistent lighting and angles.
• Trend Data: A comparison showing direction of change over 2-3 comparison windows.
• Adherence Log: A record of any supplements, topicals, or medications you have used, including start dates and dosages.
• Context Notes: Any confounders like recent stress, illness, medication changes, or diet shifts that could explain temporary shedding.

A dermatologist can use a Trichoscope to look for follicle diameter diversity, miniaturized hairs, and follicular unit density. Your tracking data provides the “Time-Series” context that a single office visit lacks. Together, the clinical exam and your longitudinal data create a complete diagnostic picture.

7. Why is capturing a hair loss baseline the most important first step?

Capturing a baseline is the most important first step because without a clean reference point, every future comparison is subjective guesswork driven by anxiety rather than evidence. MPB is only scary when it is unmeasured. Once you have a high-fidelity baseline and a zone-specific tracking protocol, you are no longer a victim of your genetics - you are a manager of your own health. The data tells you when to wait, when to hold, and exactly when to talk to a professional.

The single most important step you can take today is to capture a clean baseline. Not to diagnose, not to panic, but to create a reference point that your future self will be grateful for. Whether you start treatment next week or decide to watch and wait for a year, that baseline makes every future decision more informed, more rational, and less driven by anxiety.